- Camryn Hansen | September 21, 2009 8:09 PM | Cherry Hill, NJ
Category:
FDA & Prescription Drugs
One woman’s horrific experience with Phenergan, the migraine drug formerly sold by Wyeth, has finally ended in a black box label—the strongest warning offered by the...
- Mike Ferrara | March 05, 2009 8:33 PM | Cherry Hill, NJ
Category:
FDA & Prescription Drugs
In what promises to be one of the most important preemption cases to come out of the Supreme Court this year, Wyeth v. Levine was awarded yesterday by a 6-3 majority to Diana Levine, a Vermont...
- Camryn Hansen | February 28, 2009 11:43 PM | Cherry Hill, NJ
Category:
FDA & Prescription Drugs
Last November, the US Supreme Court heard arguments for Wyeth v. Levine, a crucial preemption case which will decide whether federal law preempts a state law tort action challenging the FDA...
- Mike Ferrara | November 19, 2008 6:22 PM | Cherry Hill, NJ
Category:
FDA & Prescription Drugs
On Monday, the Supreme Court will begin hearing oral arguments in Wyeth v. Levine, which, while deciding whether or not the drug company Wyeth should award damages to plaintiff Diana Levine for...
- Camryn Hansen | November 11, 2008 10:55 PM | Cherry Hill, NJ
Category:
FDA & Prescription Drugs
This week, as the US Supreme Court hears the case of Wyeth v. Levine, centered around the FDA’s continued approval of the Wyeth migraine drug Phenergan for intravenous use via the IV push...
- Mike Ferrara | November 03, 2008 7:08 AM | Cherry Hill, NJ
Category:
FDA & Prescription Drugs
This week, the US Supreme Court will begin hearing Wyeth v. Levine, the Court’s third preemption case in less than a year.
At issue in the case is one woman’s horrific experience with...